Chinook Therapeutics Inc Cvr (ADRO)
EBITDA Margin
-221.85%
TTM · Period ending:
ADRO EBITDA Margin
Latest reported-221.85%period ending
Latest reported-221.85%period ending
ADRO TTM EBITDA Margin (-230.34% → -221.85%)
TTM ebitda margin
High-resolution chart · PNG
ADRO ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -221.849% | |
| -243.4039% | |
| -255.9479% | |
| -463.0954% | |
| -531.1542% | |
| -596.2654% | |
| -751.2179% | |
| -604.4078% | |
| -570.8859% | |
| -576.1834% | |
| -477.3664% | |
| -575.6888% | |
| -557.2778% | |
| -530.7298% | |
| -130.1608% | |
| -132.4599% | |
| -49.5522% | |
| -17.3468% | |
| -69.9474% | |
| -52.8714% | |
| -113.2761% | |
| -217.4285% | |
| -230.3366% |